BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 31071367)

  • 21. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy.
    Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease and liver transplantation.
    Khan RS; Newsome PN
    Metabolism; 2016 Aug; 65(8):1208-23. PubMed ID: 26997540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
    Charlton MR; Burns JM; Pedersen RA; Watt KD; Heimbach JK; Dierkhising RA
    Gastroenterology; 2011 Oct; 141(4):1249-53. PubMed ID: 21726509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Cepeda-Franco C; Bernal-Bellido C; Barrera-Pulido L; Álamo-Martínez JM; Ruiz-Matas JH; Suárez-Artacho G; Marín-Gómez LM; Tinoco-González J; Díaz-Aunión C; Padillo-Ruiz FJ; Gómez-Bravo MÁ
    Transplant Proc; 2016 Nov; 48(9):2983-2986. PubMed ID: 27932125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand.
    Calzadilla-Bertot L; Jeffrey GP; Jacques B; McCaughan G; Crawford M; Angus P; Jones R; Gane E; Munn S; Macdonald G; Fawcett J; Wigg A; Chen J; Fink M; Adams LA
    Liver Transpl; 2019 Jan; 25(1):25-34. PubMed ID: 30609187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
    BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis.
    Lamm R; Altshuler PJ; Patel K; Shaheen O; Amante AP; Civan J; Maley W; Frank A; Ramirez C; Glorioso J; Shah A; Dang H; Bodzin AS
    Transpl Int; 2022; 35():10175. PubMed ID: 35865863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
    Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
    Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
    Nasser-Ghodsi N; Mara K; Watt KD
    Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States.
    Jamil OK; Sandikçi B; Faust N; Cotter TG; Paul S; di Sabato D; Fung J; Charlton M
    Transplantation; 2022 Oct; 106(10):2006-2018. PubMed ID: 35765128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.
    Yang JD; Ahmed F; Mara KC; Addissie BD; Allen AM; Gores GJ; Roberts LR
    Hepatology; 2020 Mar; 71(3):907-916. PubMed ID: 31309602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients.
    Stepanova M; Kabbara K; Mohess D; Verma M; Roche-Green A; AlQahtani S; Ong J; Burra P; Younossi ZM
    Hepatol Commun; 2022 Jul; 6(7):1506-1515. PubMed ID: 35224886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAFLD and liver transplantation: Disease burden, current management and future challenges.
    Burra P; Becchetti C; Germani G
    JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
    Holmer M; Melum E; Isoniemi H; Ericzon BG; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line PD; Stål P; Bennet W; Hagström H
    Liver Int; 2018 Nov; 38(11):2082-2090. PubMed ID: 29630771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
    Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
    Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.
    Henson JB; Wilder JM; Kappus MR; Barbas AS; Moylan CA; Niedzwiecki D; Muir AJ; Berg CL; Patel YA
    Transplantation; 2020 Jun; 104(6):e164-e173. PubMed ID: 32150036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.